In pharmacology and biochemistry, allosteric modulators are a group of substances that bind to a receptor to change that receptor's response to stimuli. Some of them, like benzodiazepines or alcoholic beverages, function as psychoactive drugs. The site that an allosteric modulator binds to (i.e., an allosteric site) is not the same one to which an endogenous agonist of the receptor would bind (i.e., an orthosteric site). Modulators and agonists can both be called receptor ligands.
Allosteric modulators can be 1 of 3 types either: positive, negative or neutral. Positive types increase the response of the receptor by increasing the probability that an agonist will bind to a receptor (i.e. affinity), increasing its ability to activate the receptor (i.e. efficacy), or both. Negative types decrease the agonist affinity and/or efficacy. Neutral types don't affect agonist activity but can stop other modulators from binding to an allosteric site. Some modulators also work as allosteric agonists and yield an agonistic effect by themselves.
The term "allosteric" derives from the Greek language. Allos means "other", and stereos, "solid" or "shape". This can be translated to "other shape", which indicates the conformational changes within receptors caused by the modulators through which the modulators affect the receptor function.
Allosteric modulators can alter the affinity and efficacy of other substances acting on a receptor. A modulator may also increase affinity and lower efficacy or vice versa. Affinity is the ability of a substance to bind to a receptor. Efficacy is the ability of a substance to activate a receptor, given as a percentage of the ability of the substance to activate the receptor as compared to the receptor's endogenous agonist. If efficacy is zero, the substance is considered an antagonist.
The site to which endogenous agonists bind to is named the orthosteric site. Modulators don't bind to this site. They bind to any other suitable sites, which are named allosteric sites.
Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.
This course introduces the student to the fudamentals of pharmacology, pharmacokinetics and drug-receptor interactions. It discusses also pharmacogenetics and chronopharmacology, to exemplify the chal
Presentation of selected signalling pathways with emphasis on both the mechanism of action of the molecules involved, molecular interactions and the role of their spatio-temporal organization within t
Alcohol, sometimes referred to by the chemical name ethanol, is a depressant drug that is the active ingredient in drinks such as beer, wine, and distilled spirits (hard liquor). It is one of the oldest and most commonly consumed recreational drugs, causing the characteristic effects of alcohol intoxication ("drunkenness"). Among other effects, alcohol produces happiness and euphoria, decreased anxiety, increased sociability, sedation, impairment of cognitive, memory, motor, and sensory function, and generalized depression of central nervous system (CNS) function.
L'acide γ-aminobutyrique, souvent abrégé en GABA (de l'anglais gamma-aminobutyric acid), est le principal neurotransmetteur inhibiteur du système nerveux central chez les mammifères et les oiseaux. Chez les insectes, il est présent dans tout l'organisme. C'est un neuromodulateur reconnu comme étant inhibiteur chez l'adulte mais excitateur lors du développement embryonnaire humain. Il joue un rôle important chez l'adulte en empêchant l'excitation prolongée des neurones.
Les barbituriques appartiennent à une famille médicamenteuse agissant comme dépresseurs du système nerveux central, et dont le spectre d'activité s'étend de l'effet sédatif à l'anesthésie. Certains sont aussi utilisés pour leurs vertus anticonvulsivantes. Tous sont dérivés de l'acide barbiturique et de ses homologues (acide thiobarbiturique, acide iminobarbiturique). Ils sont de nos jours beaucoup moins prescrits en raison de leurs effets indésirables, du risque d'abus, et de l'arrivée sur le marché de molécules à l'action comparable mais aux effets secondaires réduits et à la toxicité limitée (entre autres les benzodiazépines).
Explore les interactions ligand-récepteur, les effets des médicaments, les mécanismes de modulation et les facteurs influençant les réponses aux médicaments.
Explore la structure et la fonction des récepteurs nicotiniques, en se concentrant sur les récepteurs de la boucle Cys, la conductance ionique et les effets de la nicotine.
The phenomenon of allostery, a general property in proteins that has been heralded as "the second secret of life" remains elusive to our understanding and even more challenging to incorporate into protein design. One example of allosteric proteins with gre ...
Preventing the misfolding or aggregation of TDP-43 is the most actively pursued disease-modifying strategy to treat amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. In our work, we provide proof of concept that native state stabili ...
EPFL2024
, , ,
G-protein-coupled receptors (GPCRs) are the largest class of cell surface receptors and drug targets, and respond to a wide variety of chemical stimuli to activate diverse cellular functions. Understanding and predicting how ligand binding triggers a speci ...